Novation Pharmaceuticals

Novation Pharmaceuticals is a spin out from Novartis Pharma. The company is focused on developing a breakthrough small-molecule drug discovery technology that harnesses mRNA modulation. This technology enables the identification of new compounds for "so-called" non-drugable targets, with applications across a broad range of disease areas. Novation Pharmaceuticals' strategy involves the development of its own products in the areas of oncology and inflammation, while also generating revenues through drug-discovery collaborations with pharma companies. The company operates in the industries of Health and Wellness and Pharmaceutical. As of now, there is no publicly available information on the company's founding date, headquarters location, or past investments and investors.